J. Tami

Statistics

Publications

Citations

485

H-Index

Active since

1986

Affiliations

University of Alberta(Current)

Ionis Pharmaceuticals (United States)

The University of Texas at San Antonio Health Science Center

J. Tami is an author at University of Alberta specializing in inflammatory bowel disease activity assessment, gastrointestinal inflammation, and gastrointestinal pharmacotherapy.

Publications per year

1986–2002

Publications

Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease

Bruce Yacyshyn, W. Y. Chey, J S Goff et al. · Gut · 2002 · 223 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Monoclonal antibody technology.

J. Tami, PARR, SA Brown et al. · PubMed · 1986 · 174 citations

Life Sciences, Biotechnology, Immunology +17

Dose ranging pharmacokinetic trial of high‐dose alicaforsen (intercellular adhesion molecule‐1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease

Bruce Yacyshyn, Charles F. Barish, J S Goff et al. · Alimentary Pharmacology & Therapeutics · 2002 · 70 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

T cell hybridomas reactive with the acetylcholine receptor and its subunits.

J. Tami, Olgui E. Urso, K A Krolick · The Journal of Immunology · 1987 · 18 citations

Life Sciences, Biochemistry, Immunology +11

1–4 of 4